Main menu

Resolving vector insertion sites and cell line characterization with long-read sequencing: insights from PRINT

  • Published on:

In this on-demand webinar, hear Kyle Burbach (Addition Therapeutics) present data from platform development and pre-clinical work using PRINT, a site-specific transgene integration platform. The talk highlights the use of Oxford Nanopore long-read sequencing to investigate insertion specificity in primary human hepatocytes, characterize rDNA methylation, assess transgene integrity, and apply sensitive alignment strategies for accurate detection of integration events.

You'll also get an overview of nanopore sequencing, and see how Oxford Nanopore platforms can support vector insertion site analysis using approaches such as whole-genome sequencing and adaptive sampling.

Authors: Kyle Burbach, Addition Therapeutics; Mia Rapoza Peterson, Oxford Nanopore Technologies

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

知识产权 Cookie 政策 企业报告 隐私政策 条件条款 Modern slavery policy 前瞻性陈述

关于 Oxford Nanopore

联系我们 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag